Richmond Pharmacology recently welcomed STEM leaders from Snowsfield Primary School, marking a follow-up to our donation of STEM books for their library. Spearheaded by our CEO Dr. Jorg Taubel and Chief Medical Officer Dr. Ulrike Lorch, this effort aims to kindle enthusiasm for STEM subjects, nurturing budding scientists.

During their visit to our London Bridge facility, our Director of Clinical Operations, Samarjit Singh, shared our work's essence. With over 17 years here, his journey from team junior to his current role embodies our commitment to swiftly delivering new medicines for better patient outcomes.

The kids engaged in a mock screening, deciding whether volunteers resembled snowmen or gingerbread men. This mimicked our routine clinical assessments, such as measuring heart signals, crucial in our research. This included measuring the electrical signal the heart makes.

We also want to thank Junko Uno and Daniel Gomez Lozano for volunteering to be patients for the visit.

The kids' feedback was delightful, expressing sheer enjoyment and gratitude for the tests and engaging machinery. 

“Everything, especially the tests! THANK YOU EVER SO MUCH!.... I really enjoyed my visit”

“I enjoyed the complex machines and the interesting tests on some staff. It was a fun experiment with some of my classmates. I enjoyed coming here😊 “

Mr. Finch, Year 6 teacher and Head of Science, praised the visit, excitedly planning to integrate these experiences into their curriculum. This collaboration promises to ignite further STEM interest among the children.

“The trip was an exciting opportunity for the children to experience a working testing area within their local community where they were shown an array of possible career opportunities for the future. The visit touched on areas of the science and PSHE curriculum which we can now refer back to in lessons, making the learning less abstract and more meaningful. The children thoroughly enjoyed themselves and I hope we can continue working with Richmond Pharmacology in the future” – Adam Finch

Latest news

Richmond enrols first patients in Verve Therapeutic’s Heart-2 trial - pioneering a new approach to cardiovascular disease

June 27, 2024
Richmond enrols and doses the first patient in a clinical trial aimed at transforming the care of cardiovascular disease with single treatment gene-editing medicines.
Read more

A first of a kind trial in the fight against malaria

June 12, 2024
Richmond successfully recruits and enrols adults of sub-Saharan ancestry who all complete a first of its kind trial in the treatment of malaria.
Read more


AHA Hypertension Scientific Sessions 2024

5 - 8 September 2024
Dr. Jörg Taubel, CEO of Richmond Pharmacology, will be attending the Hypertension 2024 Scientific Sessions
View event